Advertisement
OtherArticle

Development of a novel HEK293 cell model lacking SLC29A1 to study the pharmacology of endogenous SLC29A2-encoded equilibrative nucleoside transporter subtype 2

Nayiar Shahid, Christopher Cromwell, Basil P Hubbard and James R Hammond
Drug Metabolism and Disposition July 25, 2024, DMD-AR-2024-001814; DOI: https://doi.org/10.1124/dmd.124.001814

Article Information

DMD-AR-2024-001814
DOI 
https://doi.org/10.1124/dmd.124.001814
PubMed 
39054074
Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0090-9556
Online ISSN 
1521-009X
History 
  • Published online July 25, 2024.
Copyright & Usage 
© 2024 The Authors. This is an open access article under the terms of the Creative Commons Attribution Non-Commercial License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited and is not used for commercial purposes.

Author Information

  1. Nayiar Shahid1,
  2. Christopher Cromwell1,
  3. Basil P Hubbard1, and
  4. James R Hammond1,*
  1. 1Pharmacology, University of Alberta, Canada
  1. ↵* Corresponding Author:
    James R Hammond, Pharmacology, University of Alberta, 9-70 Medical Sciences Building, Edmonton, N/A, T6G 2H7, Canada. E-mail: james.hammond{at}ualberta.ca

Statistics from Altmetric.com

Article usage

Article usage: July 2024 to September 2024

AbstractFullPdf
Jul 2024231057
Aug 2024269065
Sep 202431018

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools

OtherArticle

A novel cell model to examine the characteristics of ENT2

Nayiar Shahid, Christopher Cromwell, Basil P Hubbard and James R Hammond
Drug Metabolism and Disposition July 25, 2024, DMD-AR-2024-001814; DOI: https://doi.org/10.1124/dmd.124.001814
Twitter logo Facebook logo Mendeley logo

Jump to section

Advertisement